paroxetine has been researched along with 1-(3-chlorophenyl)piperazine in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 9 (69.23) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buck, LB; Petrascheck, M; Ye, X | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R | 1 |
Blackburn, TP; de Biasi, V; Kennett, GA; Lightowler, S; Stevens, NC; Tulloch, IF; Wood, MD | 1 |
Cowen, PJ; Quested, DJ; Sargent, PA | 1 |
Bell, CJ; Malizia, AL; Nutt, DJ | 1 |
Bull, EJ; Fone, KC; Hutson, PH | 1 |
Gauvin, L; Israël, M; Ng Ying Kin, NM; Steiger, H; Young, SN | 1 |
Gauvin, L; Israël, M; Kin, NM; Roussin, J; Steiger, H; Young, SN | 1 |
Imanishi, T; Kojima, M; Nagase, K; Tatebayashi, T; Yamauchi, M | 1 |
Hill, KP; Kuhn, C; Lee, T; Mannelli, P; Patkar, AA; Peindl, K; Wu, LT | 1 |
Amitani, H; Asakawa, A; Fujimiya, M; Fujitsuka, N; Hayashi, M; Inui, A; Kojima, S; Sameshima, M | 1 |
Chevarin, C; Hamon, M; Lanfumey, L; Maldonado, R; Martin, CB; Mongeau, R; Robledo, P | 1 |
1 review(s) available for paroxetine and 1-(3-chlorophenyl)piperazine
Article | Year |
---|---|
Brain mechanisms of social anxiety disorder.
Topics: Animals; Brain; Caffeine; Carbon Dioxide; Cholecystokinin; Dopamine; Fear; Fenfluramine; Humans; Panic Disorder; Paroxetine; Phobic Disorders; Piperazines; Rats; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin; Tomography, Emission-Computed | 1998 |
1 trial(s) available for paroxetine and 1-(3-chlorophenyl)piperazine
Article | Year |
---|---|
SSRI treatment decreases prolactin and hyperthermic responses to mCPP.
Topics: Adult; Area Under Curve; Body Temperature; Cross-Over Studies; Female; Fever; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Single-Blind Method | 1997 |
11 other study(ies) available for paroxetine and 1-(3-chlorophenyl)piperazine
Article | Year |
---|---|
An antidepressant that extends lifespan in adult Caenorhabditis elegans.
Topics: Aging; Animals; Antidepressive Agents; Caenorhabditis elegans; Caloric Restriction; Humans; Longevity; Methiothepin; Mianserin; Octopamine; Receptors, Biogenic Amine; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Signal Transduction; Starvation | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physical binding pocket induction for affinity prediction.
Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A | 2009 |
Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function.
Topics: Animals; Brain; Clomipramine; Desipramine; Fluoxetine; Male; Motor Activity; Norepinephrine; Paroxetine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Time Factors | 1994 |
Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity.
Topics: Animals; Brain; Corticosterone; Exploratory Behavior; Hydroxyindoleacetic Acid; Hypothermia; In Vitro Techniques; Male; Maze Learning; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Piperazines; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Social Behavior; Substance Withdrawal Syndrome | 2003 |
Implications of compulsive and impulsive traits for serotonin status in women with bulimia nervosa.
Topics: Adolescent; Adult; Blood Platelets; Body Mass Index; Brain; Bulimia; Carrier Proteins; Compulsive Personality Disorder; Female; Humans; Paroxetine; Personality Disorders; Personality Inventory; Piperazines; Prolactin; Receptors, Drug; Risk Factors; Serotonin | 2003 |
Serotonin function, personality-trait variations, and childhood abuse in women with bulimia-spectrum eating disorders.
Topics: Adolescent; Adult; Blood Platelets; Body Mass Index; Borderline Personality Disorder; Bulimia; Child; Child Abuse, Sexual; Cluster Analysis; Comorbidity; Compulsive Personality Disorder; Female; Humans; Middle Aged; Paroxetine; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists | 2004 |
Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Fluvoxamine; Hypokinesia; Male; Motor Activity; Paroxetine; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 2004 |
Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence.
Topics: Binding Sites; Binding, Competitive; Black or African American; Blood Platelets; Cocaine-Related Disorders; Female; Humans; Male; Multivariate Analysis; Paroxetine; Piperazines; Prolactin; Radioimmunoassay; Radioligand Assay; Regression Analysis; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Severity of Illness Index; Tritium | 2008 |
Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin.
Topics: Animals; Drugs, Chinese Herbal; Eating; Fenfluramine; Fluoxetine; Fluvoxamine; Gastrointestinal Motility; Ghrelin; Growth Hormone; Injections, Intraventricular; Male; Oligopeptides; Paroxetine; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Receptors, Ghrelin; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2009 |
5-HT2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment.
Topics: Amphetamines; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Brain; Ethylamines; Extracellular Fluid; Gene Expression Regulation; Indoles; Interpersonal Relations; Male; Mice; Mice, Inbred C57BL; Motor Activity; Paroxetine; Piperazines; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin Receptor Agonists; Stress, Psychological | 2010 |